Case study

AMIX Nutrition and IMA Active: technological evolution supporting next generation sports nutrition.

  • Reading time 5 min


  1. A study by


  2. In collaboration with:

Introduction

For more than two decades, AMIX Nutrition has been a recognised name in the field of high-performance sports supplementation. The company has built its reputation on a rigorous approach to product development, combining premium ingredients, often supported by scientific evidence and patented materials, with reliable in-house manufacturing capabilities. Its distribution network covers most of Europe and selected international markets, serving professional athletes, dedicated fitness users and specialised retail partners. Today, AMIX stands out for its strong technological orientation and its ability to deliver safe, effective and consistently manufactured formulations, supporting a market that demands both innovation and product integrity.

Company background

An evolution driven by quality

Since its foundation, AMIX Nutrition has followed a development path focused on the direct control of production processes and on the use of scientifically validated ingredients. Continuous investments in research, automation and advanced equipment have strengthened the company’s ability to manage increasing volumes while preserving consistency of formulation and performance.

Position within the nutraceutical landscape

Within the broader nutraceutical industry, AMIX operates in the segment of performance formulations. Its combination of premium ingredients, in-house manufacturing and operational flexibility represents a distinctive positioning, ensuring close control over critical quality parameters and the ability to adapt rapidly to the evolving demands of the market. Markets and applications AMIX serves a diversified customer base that includes strength and endurance athletes, fitness enthusiasts and specialised retailers across Europe. The company’s industrial structure enables a swift response to emerging trends, more complex formulations and new product categories.

Markets and applications

AMIX serves a diversified customer base that includes strength and endurance athletes, fitness enthusiasts and specialised retailers across Europe. The company’s industrial structure enables a swift response to emerging trends, more complex formulations and new product categories.

Looking back at your long history with the PRACTICA series, what were the main reasons behind your consistent trust in this platform?

The long history between AMIX and the PRACTICA series is emblematic of a partnership built on reliability and consistent performance. From the first PRACTICA 100 installed in 2015, followed by additional units in 2016 and 2022, to the introduction of the PRACTICA 200 in 2025, the company has progressively standardised its production on a technological family that has proven robust and versatile.
This continuity has supported AMIX in several areas: scalability when shifting from smaller to larger volumes, modular configuration management and stable, repeatable processes — essential in the sports nutrition segment. Operator training and spare parts management also benefit from working within a single technological platform, contributing to long-term efficiency and production stability.

Considering the installation of HERMETICA and the ZANASI 40 in 2022, what potential benefits or expectations led you to choose these technologies to expand your production capacity?

In 2022, AMIX expanded its equipment portfolio with two additional solutions: HERMETICA and the ZANASI 40. These technologies represent a key step toward increasingly diversified and technically demanding applications.
HERMETICA introduces new possibilities for handling sensitive products and liquid formulations, while the ZANASI 40 enables access to processes such as pellet filling and other high value applications that are gaining in relevance for advanced performance nutrition. These investments reflect the company’s intention to broaden its technological capabilities and prepare for the development of more sophisticated dosage forms.

As you prepare to move into more complex applications, such as liquid filling, how do you expect IMA Active to support you during this transition?

Expanding into segments such as liquid filling and pellet filling involves specific challenges linked to process validation, stability control and integration with existing workflows. AMIX expects to rely on IMA Active’s technical consultancy and engineering expertise during the transition, ensuring that new processes are properly tuned, validated and aligned with its quality and regulatory standards.

How would you describe your experience with IMA’s after-sales support over the years?

Over the years, AMIX has developed a consistently positive experience with IMA Active’s after sales support. Responsiveness, technical know how and a structured approach to maintenance have been essential to safeguard production continuity. The ability to address issues quickly and to plan interventions effectively has contributed to minimising downtime and preserving equipment performance.

How do you perceive the collaboration with IMA Active when it comes to upgrades, process optimisation and continuous improvement of your equipment fleet?

The collaboration between AMIX and IMA Active has progressively evolved into a technological partnership. Continuous upgrades, process optimisation and performance improvements play a central role in keeping the equipment fleet aligned with a fast moving nutraceutical market. AMIX values the long term vision and proactive approach that support its ongoing competitiveness.

How do you envision your partnership with IMA evolving to meet these future challenges?

AMIX envisions a future where its collaboration with IMA deepens through greater technological integration, digitalisation and support for increasingly complex dosage forms. As product sophistication and regulatory expectations continue to grow, the presence of a reliable and technologically advanced partner becomes a key element of the company’s strategic development.
Transparency, long-term planning and shared innovation objectives will continue to guide the partnership, supporting AMIX in expanding its capabilities and strengthening its role in the evolving landscape of performance nutrition.

Up to 200,000 caps/h

IMA S.p.A. – Active Division

PRACTICA

Capsule Filling

ZANASI

Capsule Filling

Up to 40,000 caps/h

IMA S.p.A. – Active Division

HERMETICA

Capsule Filling

Up to 100,000 caps/h

IMA S.p.A. – Active Division

Related insights

White paper

Salty compression.

5 min

Brands: IMA Active, IMA S.p.A. – Active Division

8 min

Brands: IMA Active, IMA Safe, IMA S.p.A. – Safe Division, IMA S.p.A. – Active Division